| 000 | 01585 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514212743.0 | ||
| 264 | 0 | _c20050318 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a1368-5031 | ||
| 024 | 7 |
_a10.1111/j.1742-1241.2004.00162.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMercanoglu, F | |
| 245 | 0 | 0 |
_aImpaired brachial endothelial function in patients with primary anti-phospholipid syndrome. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _cNov 2004 |
||
| 300 |
_a1003-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiphospholipid Syndrome _xphysiopathology |
| 650 | 0 | 4 |
_aArteriosclerosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aBrachial Artery _xdiagnostic imaging |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aUltrasonography |
| 650 | 0 | 4 |
_aVascular Diseases _xdiagnostic imaging |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aErdogan, D | |
| 700 | 1 | _aOflaz, H | |
| 700 | 1 | _aKücükkaya, R | |
| 700 | 1 | _aSelcukbiricik, F | |
| 700 | 1 | _aGül, A | |
| 700 | 1 | _aInanc, M | |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 58 _gno. 11 _gp. 1003-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-1241.2004.00162.x _zAvailable from publisher's website |
| 999 |
_c15287727 _d15287727 |
||